Supplemental Guidance on Testing for Replication-Competent Retrovirus in Retroviral Vector-Based Gene Therapy Products and During Follow-Up of Patients in Clinical Trials Using Retroviral Vectors

Human Gene Therapy - United States
doi 10.1089/10430340150218440
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Mary Ann Liebert Inc


Related search